Prostate cancer screening and diagnosis: Genetic tests applications in High-risk PCa (Decipher, 4k, PHI, GPS, urinary markers, exosomes, etc). Do we have benefits? When should I order?
High-Risk and Locally Advanced Prostate Cancer: Genomic test applications in high-risk and patients with family history of PCa: When should I use? Pre-Recorded lecture
High-Risk and Locally Advanced Prostate Cancer: Radiation protocols in HR disease ( prostate RT vs. Prostate and pelvis vs. prostate lesion RT boost) Pre-Recorded lecture
High-Risk and Locally Advanced Prostate Cancer: Clinical cases discussion- Challenging cases of prostate cancer: experience from a high-volume referral center
Recurrent Disease After Local Treatment: Applications of PSMA Pet in staging PCa recurrence. When should I order and how should I do the interpretation?
Location: IRCAD- Hirsch Auditorium
Uro Onc Course
Wednesday, Jul 16th
11:00 AM - 11:10 AM CEST
Recurrent Disease After Local Treatment: PSA persistence after surgery : medical oncologist approach (Pre-Recorded Lecture)
Recurrent Disease After Local Treatment: Selecting the best salvage treatment after non-surgical treatment failure for localized prostate cancer? Surgery vs. RT vs. Ablation
Oligometastatic disease: Current role of RT + Hormone deprivation in Oligometastatic disease. Should we use ADT in all candidates? Should we irradiate the metastasis as well?
